1. Home
  2. RGEN vs ALB Comparison

RGEN vs ALB Comparison

Compare RGEN & ALB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • ALB
  • Stock Information
  • Founded
  • RGEN 1981
  • ALB 1994
  • Country
  • RGEN United States
  • ALB United States
  • Employees
  • RGEN N/A
  • ALB N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • ALB Major Chemicals
  • Sector
  • RGEN Health Care
  • ALB Industrials
  • Exchange
  • RGEN Nasdaq
  • ALB Nasdaq
  • Market Cap
  • RGEN 7.6B
  • ALB 11.7B
  • IPO Year
  • RGEN N/A
  • ALB 1994
  • Fundamental
  • Price
  • RGEN $156.55
  • ALB $92.69
  • Analyst Decision
  • RGEN Buy
  • ALB Hold
  • Analyst Count
  • RGEN 12
  • ALB 22
  • Target Price
  • RGEN $187.44
  • ALB $114.86
  • AVG Volume (30 Days)
  • RGEN 470.1K
  • ALB 1.9M
  • Earning Date
  • RGEN 02-19-2025
  • ALB 02-12-2025
  • Dividend Yield
  • RGEN N/A
  • ALB 1.75%
  • EPS Growth
  • RGEN N/A
  • ALB N/A
  • EPS
  • RGEN N/A
  • ALB N/A
  • Revenue
  • RGEN $633,513,000.00
  • ALB $6,501,978,000.00
  • Revenue This Year
  • RGEN $2.28
  • ALB N/A
  • Revenue Next Year
  • RGEN $9.88
  • ALB N/A
  • P/E Ratio
  • RGEN N/A
  • ALB N/A
  • Revenue Growth
  • RGEN N/A
  • ALB N/A
  • 52 Week Low
  • RGEN $113.50
  • ALB $71.97
  • 52 Week High
  • RGEN $211.13
  • ALB $143.19
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 60.07
  • ALB 49.53
  • Support Level
  • RGEN $149.15
  • ALB $84.88
  • Resistance Level
  • RGEN $160.64
  • ALB $93.06
  • Average True Range (ATR)
  • RGEN 5.96
  • ALB 2.92
  • MACD
  • RGEN 0.91
  • ALB 0.73
  • Stochastic Oscillator
  • RGEN 79.57
  • ALB 80.43

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About ALB Albemarle Corporation

Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants. It is also a major producer of oil refining catalysts.

Share on Social Networks: